Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. van Waalwijk van Doorn-Khosrov, Badrising SK, Burgers S. N Engl J Med 2024;390:478.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van Waalwijk van Doorn-Khosrov, Badrising SK, Burgers S. Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. N Engl J Med 2024;390:478.
PMID: 38294983